Back

Rat somatic genome editing enables ER+ breast cancer modeling

Bu, W.; Lee, T. K.; Anurag, M.; Ding, Y.; Xu, R.; He, L.; Bu, A. Z.; Nagi, C. K.; Gutierrez, C.; Hilsenbeck, S. K.; Cheng, C.; Zhang, B.; Huang, S.; Xu, J.; Osborne, C. K.; Sreekumar, A.; Chang, E.; Creighton, C. J.; Zhang, X.; Li, Y.

2025-09-18 cancer biology
10.1101/2025.09.15.675961 bioRxiv
Show abstract

Genetically engineered mouse models have advanced cancer research but often fail to capture key features of certain human tumors. Rats, with distinct physiology and tumor biology, offer a powerful alternative, yet their use has been constrained by technical barriers to genome editing. Here, we report efficient somatic genome editing in rats, enabling both Indel and substitution mutations. We then apply this approach to model estrogen receptor (ER)-positive breast cancer, which accounts for [~]70% of human cases but remains poorly represented in mice. The resulting rat tumors reproduce hallmarks of human ER+ breast cancer, including ductal histology, hormone responsiveness, and immune-microenvironmental features. By contrast, identical genetic alterations in mice failed to yield ER+ tumors, underscoring critical species differences in tumorigenesis. Together, this work establishes a versatile platform for rapid generation of clinically relevant rat tumor models, opening new avenues to dissect tumor biology, therapeutic response, and immune interactions in previously inaccessible cancer subtypes.

Published in Proceedings of the National Academy of Sciences (predicted rank #7) · training set

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.